International Clinical Trial: Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213934) titled 'Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma' on Sept. 30.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Cincinnati

Condition: Head and Neck Cancer Recurrent Head and Neck Squamous Cell Carcinoma

Intervention: Radiation: Proton therapy

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: December 2025

Target Sample Size: 40

Coun...